1. Acknowledgement

   Announcement 17 September 2012 Pages: 1065 - 1067

2. Is There A Role For Pharmacoeconomics In Developing Countries?

   • Zaheer-Ud-Din Babar
   • Shane Scahill

   Commentary 17 September 2012 Pages: 1069 - 1074

   

3. The Economics of a ‘Liberated’ NHS

   • Nancy J. Devlin

   Commentary 17 September 2012 Pages: 1075 - 1078

4. The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions

   • Andrea Manca
   • Mark J. Sculpher
   • Ron Goeree

   Leading Article 17 September 2012 Pages: 1079 - 1096

   

5. Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices

   • Lizheng Shi
   • Jinan Liu
   • Manjiri Pawaskar

   Review Article 17 September 2012 Pages: 1097 - 1107

   

6. A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States

   • Ifigeneia Mavranezouli

   Review Article 17 September 2012 Pages: 1109 - 1121

   

7. Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance

   • Klaus Kaier
   • Uwe Frank

   Original Research Article 17 September 2012 Pages: 1123 - 1128

   

8. The Cost Utility of Autologous Chondrocytes Implantation Using ChondroCelect® in Symptomatic Knee Cartilage Lesions in Belgium

   • Laetitia Gerlier
   • Mark Lamotte
   • François M. Meurgey

   Original Research Article 17 September 2012 Pages: 1129 - 1146